Vector Biosystems, Inc.
Malvern, PA Doing business as Vector Biolabs Part of Fortis Life Sciences, LLC
- UEI
- KWA7MHCG9E91
- CAGE
- 4FFE8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
TNV6UD7CKCJ9
-
Parent
TNV6UD7CKCJ9
- SAM.gov registration date
- Physical address
- 293 Great Valley Pkwy, Malvern, PA 19355, USA
- Website
- vectorbiolabs.com
- Founded
- 2004
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | -$15 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $37,590 |
| FY2023 | $36,260 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Vector Biosystems, Inc., doing business as Vector Biolabs, is a minority-owned, self-certified small disadvantaged, for-profit biotechnology company registered in SAM.gov since 2006. Located in Malvern, Pennsylvania, the firm specializes in gene delivery products and services, with a primary focus on developing advanced viral vector constructs for biomedical research. The company's core competency lies in creating custom adeno-associated viral (AAV) vectors that are utilized by various national research institutes for sophisticated gene therapy and scientific research applications.
The federal contract awards demonstrate Vector Biosystems' specialized work primarily with National Institutes of Health (NIH) agencies, including the National Center for Advancing Translational Sciences (NCATS), National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute, and the National Institute on Deafness and Other Communication Disorders. The company has consistently provided complex AAV viral vector constructs expressing specific proteins, fluorescent markers, and RNA interference (shRNA) targeting elements. Recent contract awards, ranging from $10,600 to $24,200, have involved delivering specialized viral vectors for research purposes, such as AAV constructs expressing green fluorescent proteins, mitochondrial and cytosolic-targeted reactive oxygen species sensitive proteins, and custom shRNA vectors targeting specific human genes. All contracts were awarded on a full and open competition basis without set-aside designations, highlighting the company's competitive positioning in providing advanced biotechnological research tools to federal agencies.
Quick answers
Is Vector Biosystems, Inc. registered in SAM.gov?
Yes. Vector Biosystems, Inc.'s SAM.gov registration is active through July 27, 2027.
How much has Vector Biosystems, Inc. received in federal contracts?
Federal contracts obligated $73,835 to Vector Biosystems, Inc. in fiscal years 2023 through 2027.
What is Vector Biosystems, Inc.'s most recent federal award?
Vector Biosystems, Inc.'s most recent federal contract award is AAV viral vector with EF1A promotor expressing a green fluorescent protein vector biosystems:1146148 [24-006779] (75N95024P00616), from National Institute on Drug Abuse (NIH), on September 16, 2024.
On GovTribe
See Vector Biosystems, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors